pith. sign in

arxiv: 2605.30591 · v1 · pith:KDT2YP3Knew · submitted 2026-05-28 · 🧬 q-bio.QM

Obesity and Sociodemographic Factors in Luminal Breast Cancer

Vacanti Anderson , Paramahansa Pramanik , Haley K. Robinson This is my paper

Pith reviewed 2026-06-28 23:24 UTC · model grok-4.3

classification 🧬 q-bio.QM
keywords luminal breast cancerBMIAfrican ancestryLuminal Bmediation analysisobesitymenopausal statusreceptor expression
0
0 comments X

The pith

Higher BMI and African ancestry independently raise odds of Luminal B breast cancer, with BMI partially mediating the ancestry link.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper evaluates 1928 Luminal A and 1610 Luminal B patients to examine links among body mass index, ancestry, menopausal status, and receptor expression. Multivariable logistic regression shows elevated BMI and African ancestry each increase the odds of Luminal B tumors while postmenopausal status decreases those odds. Mediation analysis indicates BMI accounts for part of the ancestry-subtype association. These patterns matter because Luminal B tumors carry worse prognosis than Luminal A and obesity represents a potentially changeable factor.

Core claim

In the studied cohort, patients with Luminal B tumors had higher mean BMI than those with Luminal A tumors. Multivariable analyses found elevated BMI and African ancestry independently associated with increased odds of Luminal B carcinoma, postmenopausal status associated with lower risk, and BMI partially explaining the association between ancestry and Luminal B disease.

What carries the argument

multivariable logistic regression combined with mediation analysis relating BMI, ancestry, and menopausal status to luminal subtype

If this is right

  • Elevated BMI increases the odds of Luminal B independent of ancestry and menopausal status.
  • African ancestry increases the odds of Luminal B independent of BMI.
  • Postmenopausal status decreases the odds of Luminal B.
  • BMI accounts for a portion of the observed ancestry effect on subtype.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Targeted weight-management efforts could produce larger reductions in Luminal B incidence within African-ancestry populations than in others.
  • The partial mediation leaves room for additional ancestry-linked pathways, such as differences in hormone exposure or inflammation, that future work could test directly.

Load-bearing premise

The multivariable logistic regression and mediation models have adequately controlled for all relevant confounders and the patient sample accurately represents the broader population of luminal breast cancer cases.

What would settle it

An independent cohort study that applies the same multivariable and mediation models and finds no association between BMI or ancestry and Luminal B subtype after adjustment would falsify the central claim.

Figures

Figures reproduced from arXiv: 2605.30591 by Haley K. Robinson, Paramahansa Pramanik, Vacanti Anderson.

Figure 1
Figure 1. Figure 1: Nonlinear fitted trends between MammaPrint index and estimated recurrence risk profiles. [PITH_FULL_IMAGE:figures/full_fig_p010_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Functional data analysis plot showing multiple Fourier basis curves and their corresponding scatter observa [PITH_FULL_IMAGE:figures/full_fig_p011_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Multi-panel figure showing Fourier basis functional curves, a genomic heat contour map, a three-dimensional [PITH_FULL_IMAGE:figures/full_fig_p014_3.png] view at source ↗
Figure 4
Figure 4. Figure 4: Forest plot of regression coefficients and 95% confidence intervals for variables associated with luminal breast [PITH_FULL_IMAGE:figures/full_fig_p015_4.png] view at source ↗
Figure 5
Figure 5. Figure 5: Multi-panel visualization showing dynamic particle filter approximation trajectories, a genomic heat contour [PITH_FULL_IMAGE:figures/full_fig_p016_5.png] view at source ↗
Figure 6
Figure 6. Figure 6: Multi-panel visualization of Cox proportional hazards modeling results, including hazard contour structures, [PITH_FULL_IMAGE:figures/full_fig_p019_6.png] view at source ↗
Figure 7
Figure 7. Figure 7: This is bar chart showing the group between Luminal A and B for each race. [PITH_FULL_IMAGE:figures/full_fig_p020_7.png] view at source ↗
read the original abstract

Luminal breast cancers represent the most prevalent molecular subtype of breast carcinoma, with Luminal A tumors generally associated with more favorable clinical outcomes than Luminal B tumors. Obesity-related inflammation and prolonged exposure to exogenous steroids have been implicated in the progression of luminal malignancies. This study evaluated 1,928 patients with Luminal A breast cancer and 1,610 patients with Luminal B breast cancer to examine associations among body mass index (BMI), age, ethnic background, menopausal status, and receptor expression, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Patients with Luminal B tumors demonstrated a significantly greater mean BMI compared with those with Luminal A tumors. In addition, Luminal B tumors were more frequently observed among patients of African ancestry relative to White and Hispanic populations. Multivariable analyses revealed that elevated BMI and African ancestry were independently associated with increased odds of Luminal B carcinoma, whereas postmenopausal status was associated with lower risk. Mediation analysis further indicated that BMI partially explained the association between ancestry and Luminal B disease. These findings suggest that obesity and population-specific factors may contribute to the development of more aggressive luminal breast cancer phenotypes.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

3 major / 1 minor

Summary. The manuscript examines associations in 1,928 Luminal A and 1,610 Luminal B breast cancer patients, reporting that higher BMI and African ancestry are independently linked to greater odds of Luminal B subtype while postmenopausal status is linked to lower odds; mediation analysis indicates BMI partially accounts for the ancestry association. These conclusions rest on multivariable logistic regression and mediation models applied to observational data.

Significance. If the reported associations prove robust to confounder control and model specification, the work could add to the literature on obesity and ancestry as contributors to luminal subtype differences, with possible implications for risk stratification. The mediation component, if valid, offers a potential mechanistic pathway, but the observational design inherently limits causal claims.

major comments (3)
  1. [Abstract/Methods] Abstract and Methods: No model specification details are provided, including the full list of covariates in the multivariable logistic regression, exact definitions of variables such as 'African ancestry' or receptor thresholds, missing-data handling, or whether interactions were tested. These omissions prevent verification that the 'independent' associations are not artifacts of omitted-variable bias or collinearity.
  2. [Mediation Analysis] Mediation Analysis: The claim that BMI partially mediates the ancestry-Luminal B link depends on the untestable no-unmeasured-confounding assumption across the ancestry-BMI, ancestry-subtype, and BMI-subtype pathways. No sensitivity analyses (e.g., E-value, alternative DAGs, or instrumental-variable checks) are described, rendering the mediation decomposition load-bearing yet unverifiable from the reported information.
  3. [Results] Results: The abstract asserts 'statistically significant associations' and 'greater mean BMI' without reporting odds ratios, confidence intervals, p-values, or sample sizes per subgroup, and without referencing any tables or figures that would allow evaluation of effect magnitude or precision.
minor comments (1)
  1. [Abstract] The abstract would be clearer if it explicitly stated the total sample size (3,538) and named the statistical software or packages used for the logistic and mediation models.

Simulated Author's Rebuttal

3 responses · 0 unresolved

We thank the referee for the constructive comments on our manuscript. We have prepared point-by-point responses below and will revise the manuscript accordingly to improve clarity and transparency.

read point-by-point responses

  1. Referee: [Abstract/Methods] Abstract and Methods: No model specification details are provided, including the full list of covariates in the multivariable logistic regression, exact definitions of variables such as 'African ancestry' or receptor thresholds, missing-data handling, or whether interactions were tested. These omissions prevent verification that the 'independent' associations are not artifacts of omitted-variable bias or collinearity.

    Authors: We agree that the Methods section requires greater detail on model specification. In the revised manuscript we will add the complete list of covariates included in the multivariable logistic regression, explicit definitions of African ancestry (self-reported race/ethnicity), receptor thresholds used for Luminal A/B classification, the approach to missing data, and results of any interaction tests performed. These additions will allow readers to evaluate potential omitted-variable bias or collinearity. revision: yes

  2. Referee: [Mediation Analysis] Mediation Analysis: The claim that BMI partially mediates the ancestry-Luminal B link depends on the untestable no-unmeasured-confounding assumption across the ancestry-BMI, ancestry-subtype, and BMI-subtype pathways. No sensitivity analyses (e.g., E-value, alternative DAGs, or instrumental-variable checks) are described, rendering the mediation decomposition load-bearing yet unverifiable from the reported information.

    Authors: We recognize that mediation analysis in observational data rests on strong, untestable assumptions. In revision we will explicitly articulate these assumptions in the Methods and add a dedicated limitations paragraph in the Discussion. Because the dataset does not contain instruments or additional variables suitable for formal sensitivity analyses (E-value or otherwise), we cannot perform them; we will therefore note this as a limitation rather than claim robustness beyond the reported decomposition. revision: partial

  3. Referee: [Results] Results: The abstract asserts 'statistically significant associations' and 'greater mean BMI' without reporting odds ratios, confidence intervals, p-values, or sample sizes per subgroup, and without referencing any tables or figures that would allow evaluation of effect magnitude or precision.

    Authors: We will revise the abstract to report the key odds ratios, 95% confidence intervals, and p-values for the primary associations (BMI, ancestry, menopausal status) and will include the subgroup sample sizes. We will also add explicit references to the relevant tables and figures so that effect sizes and precision can be directly evaluated. revision: yes

Circularity Check

0 steps flagged

No circularity: standard observational statistics with no derivation chain

full rationale

The paper reports empirical associations from patient data using multivariable logistic regression and mediation analysis. No mathematical derivations, fitted parameters renamed as predictions, self-citations as load-bearing premises, or ansatzes are present. All steps are direct statistical computations on the observed sample; the central claims do not reduce to their inputs by construction. This is the expected non-finding for an observational epidemiology study.

Axiom & Free-Parameter Ledger

0 free parameters · 2 axioms · 0 invented entities

Based on abstract only; the analysis rests on standard assumptions of logistic regression (linearity in logit, no unmeasured confounding) and mediation analysis (no exposure-mediator interaction, correct temporal ordering). No free parameters or invented entities are described.

axioms (2)
  • domain assumption Multivariable models correctly adjust for all confounders and the sample is free of selection bias
    Invoked implicitly when reporting independent associations and mediation results from observational data
  • standard math Standard logistic regression and mediation analysis assumptions hold (linearity, no unmeasured confounding)
    Required for interpreting odds ratios and partial mediation as stated

pith-pipeline@v0.9.1-grok · 5746 in / 1311 out tokens · 19394 ms · 2026-06-28T23:24:56.423496+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 2 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Modeling Educational Performance Using School Demographics and Teacher Characteristics

    stat.ME 2026-06 unverdicted novelty 6.0

    Introduces Adaptive Weighted Group Fused LASSO estimator with ADMM algorithm and asymptotic guarantees, demonstrated on Alabama school math proficiency data.

  2. Optimal Harvesting under Stochastic Control: HJB Equation and Feynman-Kac Representation

    math.OC 2026-06 unverdicted novelty 2.0

    Applies standard HJB and Feynman-Kac methods to stochastic harvesting models and claims they are consistent for policy design.

Reference graph

Works this paper leans on

81 extracted references · 17 canonical work pages · cited by 2 Pith papers

  1. [1]

    C., Mills, P., Bush, J., and Newman, L

    Amirikia, K. C., Mills, P., Bush, J., and Newman, L. A. (2011). Higher population-based incidence rates of triple-negative breast cancer among young african-american women: Implications for breast cancer screening recommendations. Cancer , 117(12):2747--2753

    2011

  2. [2]

    P., Patel, M

    Banegas, M. P., Patel, M. I., Aguilar, M., and Neumark-Sztainer, D. (2014). The obesity paradox in cancer: a review. CA: A Cancer Journal for Clinicians , 64(6):393--408

    2014

  3. [3]

    E., Finn, E., Sykora, P., Lynch, V

    Bulls, S. E., Finn, E., Sykora, P., Lynch, V. J., Pramanik, P., Glaberman, S., and Chiari, Y. (2025). Assessing cometchip technology for dna damage studies in non-model species: distinct uv-induced responses in turtles and mammals. BMC Research Notes , 18(1):1--7

    2025

  4. [4]

    E., Rodriguez, C., Walker-Thurmond, K., and Thun, M

    Calle, E. E., Rodriguez, C., Walker-Thurmond, K., and Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of u.s. adults. New England Journal of Medicine , 348(17):1625--1638

    2003

  5. [5]

    Carey, L., Perou, C., Livasy, C., Dressler, L., Cowan, D., Conway, K., Karaca, G., Troester, M., Tse, C., and Edmiston, S. (2006a). Race, breast cancer subtypes, and survival in the carolina breast cancer study. JAMA , 295(21):2492--2502

  6. [6]

    A., Perou, C

    Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C.-c., Edmiston, S., et al. (2006b). Race, breast cancer subtypes, and survival in the carolina breast cancer study. JAMA , 295(21):2492--2502

  7. [7]

    A., Pramanik, P., Marbut, S

    Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S. (2023). Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis. Cancer Research , 83(7\_Supplement):3318--3318

    2023

  8. [8]

    L., Banerjee, R., Alsatari, E

    Dasgupta, S., Galappaththi, S. L., Banerjee, R., Alsatari, E. S., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., and Dasgupta, S. (2026). Frequent loss of cacna1c is associated with poor prognosis in non-small cell lung cancer. The FASEB Journal , 40(4):e71614

    2026

  9. [9]

    E., Ma, J., Gaudet, M

    DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., and Siegel, R. L. (2019). Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians , 69(6):438--451

    2019

  10. [10]

    Dunbar, B., Pramanik, P., and Robinson, H. K. (2026). Modeling age-adjusted mortality in the united states. arXiv preprint arXiv:2601.13504

    work page arXiv 2026

  11. [11]

    Ellington, C., Pramanik, P., and Robinson, H. K. (2025a). Metascorelens: Evaluating user feedback across digital entertainment systems. arXiv preprint arXiv:2601.11523

    work page arXiv

  12. [12]

    Ellington, C., Pramanik, P., and Robinson, H. K. (2025b). Playmydata: A statistical analysis of a video game dataset on review scores and gaming platforms. Analytics , 4(4):31

  13. [13]

    Gaudet, M., Press, M., Haile, R., Lynch, C., Glaser, S., Schildkraut, J., Gammon, M., Douglas Thompson, W., and Bernstein, J. (2011). Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Research and Treatment , 130:587--597

    2011

  14. [14]

    A., Beresford, S

    Hastert, T. A., Beresford, S. A., and Sheppard, L. (2016). Race/ethnicity, education, and obesity in us adults: A test of the social patterning hypothesis. American Journal of Preventive Medicine , 50(1):e1--e9

    2016

  15. [15]

    L., Vikramdeo, K

    Hertweck, K. L., Vikramdeo, K. S., Galeas, J. N., Marbut, S. M., Pramanik, P., Yunus, F., Singh, S., Singh, A. P., and Dasgupta, S. (2023). Clinicopathological significance of unraveling mitochondrial pathway alterations in non-small-cell lung cancer. The FASEB Journal , 37(7):e23018

    2023

  16. [16]

    Hua, L., Polansky, A., and Pramanik, P. (2019). Assessing bivariate tail non-exchangeable dependence. Statistics & Probability Letters , 155:108556

    2019

  17. [17]

    Imai, K., Keele, L., and Yamamoto, T. (2010). Identification, inference and sensitivity analysis for causal mediation effects. Project euclid

    2010

  18. [18]

    M., Hudis, C

    Iyengar, N. M., Hudis, C. A., and Dannenberg, A. J. (2016). Obesity and cancer mechanisms: tumor microenvironment and inflammation. Journal of Clinical Oncology , 34(35):4270--4276

    2016

  19. [19]

    Joslyn, S. A. (2002). Racial differences in treatment and survival from early-stage breast carcinoma. Cancer , 95(8):1759--1766

    2002

  20. [20]

    P., Sarkar, C., and Chakroborty, D

    Kakkat, S., Pramanik, P., Singh, S., Singh, A. P., Sarkar, C., and Chakroborty, D. (2023). Cardiovascular complications in patients with prostate cancer: Potential molecular connections. International Journal of Molecular Sciences , 24(8):6984

    2023

  21. [21]

    A., Frankel, W

    Kakkat, S., Suman, P., Goswami, S., Kola, B., Bruno, K. A., Frankel, W. L., Basu, S., Turbat-Herrera, E. A., Ramirez-Alcantara, V., Heslin, M. J., et al. (2026). Angiotensin ii type 1 receptor blockade inhibits gastric cancer metastasis through tight junction restoration. bioRxiv , pages 2026--01

    2026

  22. [22]

    A., Acharya, S., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J

    Khan, M. A., Acharya, S., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J. E., Dasgupta, S., and Singh, A. P. (2023). Myb exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer. Iscience , 26(12)

    2023

  23. [23]

    A., Acharya, S., Kreitz, N., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J., Dasgupta, S., et al

    Khan, M. A., Acharya, S., Kreitz, N., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J., Dasgupta, S., et al. (2024). Mp60-05 myb exhibits racially disparate expression and clinicopathologic association and is a promising predictor of biochemical recurrence in prostate cancer. Journal of Urology , 211(5S):e1000

    2024

  24. [24]

    Kohler, B., Sherman, R., Howlader, N., Jemal, A., Ryerson, A., Henry, K., Boscoe, F., Cronin, K., Lake, A., and Noone, A.-M. (2015). Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J. Natl. Cancer Inst. , 107:djv048. CrossRef

    2015

  25. [25]

    Maki, E., Glimm, T., Pramanik, P., Chiari, Y., and Kiskowski, M. (2025). New approaches for capturing and estimating variation in complex animal color patterns from digital photographs: application to the eastern box turtle (terrapene carolina). PeerJ , 13:e19690

    2025

  26. [26]

    Munsell, M., Sprague, B., Berry, D., Chisholm, G., and Trentham-Dietz, A. (2014). Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol. Rev. , 36:114--136

    2014

  27. [27]

    R., Ambrosone, C

    Palmer, J. R., Ambrosone, C. B., and Olshan, A. F. (2014). Obesity, diabetes, and risk of breast cancer: the black women’s health study. American Journal of Epidemiology , 180(7):714--723

    2014

  28. [28]

    M., and Scherer, P

    Park, J., Euhus, D. M., and Scherer, P. E. (2017). Obesity and cancer--mechanisms underlying tumour progression and recurrence. Nature Reviews Endocrinology , 13(8):455--465

    2017

  29. [29]

    I., Chlebowski, R

    Phipps, A. I., Chlebowski, R. T., Prentice, R., McTiernan, A., Wactawski-Wende, J., Kuller, L. H., Adams-Campbell, L. L., Lane, D. S., Vitolins, M. Z., Kabat, G. C., et al. (2011). Body size and risk of luminal, her2-expressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention , 20(5):890--898

    2011

  30. [30]

    and Frankenfeld, C

    Pierobon, M. and Frankenfeld, C. L. (2013). Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Research and Treatment , 137(1):307--314

    2013

  31. [31]

    Polansky, A. M. and Pramanik, P. (2021). A motif building process for simulating random networks. Computational Statistics & Data Analysis , 162:107263

    2021

  32. [32]

    and Pramanik, P

    Powell, A. and Pramanik, P. (2025). Genomic influence of a key transcription factor in male glandular malignancy. arXiv preprint arXiv:2510.11959

    work page arXiv 2025

  33. [33]

    and Pramanik, P

    Powell, A. and Pramanik, P. (2026). The role of myb in prostate cancer: A statistical analysis. European Journal of Statistics , 6:1--1

    2026

  34. [34]

    Pramanik, P. (2016). Tail non-exchangeability . Northern Illinois University

    2016

  35. [35]

    Pramanik, P. (2020). Optimization of market stochastic dynamics. SN Operations Research Forum , 1(4):31

    2020

  36. [36]

    Pramanik, P. (2021a). Effects of water currents on fish migration through a feynman-type path integral approach under 8/3 liouville-like quantum gravity surfaces. Theory in Biosciences , 140(2):205--223

  37. [37]

    Pramanik, P. (2021b). Optimization of Dynamic Objective Functions Using Path Integrals . PhD thesis, Northern Illinois University

  38. [38]

    Pramanik, P. (2022). Stochastic control of a sir model with non-linear incidence rate through euclidean path integral. arXiv preprint arXiv:2209.13733

    work page arXiv 2022

  39. [39]

    Pramanik, P. (2023a). Consensus as a nash equilibrium of a stochastic differential game. European Journal of Statistics , 3:10--10

  40. [40]

    Pramanik, P. (2023b). Optimal lock-down intensity: A stochastic pandemic control approach of path integral. Computational and Mathematical Biophysics , 11(1):20230110

  41. [41]

    Pramanik, P. (2023c). Path integral control in infectious disease modeling. arXiv preprint arXiv:2311.02113

    work page arXiv

  42. [42]

    Pramanik, P. (2023d). Path integral control of a stochastic multi-risk sir pandemic model. Theory in Biosciences , pages 1--36

  43. [43]

    Pramanik, P. (2024a). Dependence on tail copula. J , 7(2):127--152

  44. [44]

    Pramanik, P. (2024b). Estimation of optimal lock-down and vaccination rate of a stochastic sir model: A mathematical approach. European Journal of Statistics , 4:3--3

  45. [45]

    Pramanik, P. (2024c). Measuring asymmetric tails under copula distributions. European Journal of Statistics , 4:7--7

  46. [46]

    Pramanik, P. (2024d). On estimation of function-on-function regression kernels with brownian berkson errors

  47. [47]

    Pramanik, P. (2024e). Stochastic control in determining a soccer player’s performance. J. Compr. Pure Appl. Math , 2:111

  48. [48]

    Pramanik, P. (2025a). Construction of an optimal strategy: An analytic insight through path integral control driven by a mckean--vlasov opinion dynamics. Mathematics , 13(17):2842

  49. [49]

    Pramanik, P. (2025b). Optimal feedback control in social networks in a mckean-vlasov-friedkin-johnsen system. arXiv preprint arXiv:2508.17138

    work page arXiv

  50. [50]

    Pramanik, P. (2025c). An optimal level of stubbornness to win a soccer match. arXiv preprint arXiv:2501.18050

    work page arXiv

  51. [51]

    Pramanik, P. (2025d). Stubbornness as control in professional soccer games: A bppsde approach. Mathematics , 13(3):475

  52. [52]

    Pramanik, P. (2026a). The quantum structure of markets: Linking hamiltonian-jacobi-bellman dynamics to schrodinger equation through feynman action. arXiv preprint arXiv:2603.25086

    work page arXiv

  53. [53]

    Pramanik, P. (2026b). Strategic dynamics of firms via path integral control. International Game Theory Review , page 2650006

  54. [54]

    L., and Ghanam, R

    Pramanik, P., Boone, E. L., and Ghanam, R. A. (2024a). Parametric estimation in fractional stochastic differential equation. Stats , 7(3):745

  55. [55]

    and Dong, L

    Pramanik, P. and Dong, L. (2025a). Impact of random monetary shock: a keynesian case. arXiv preprint arXiv:2505.00800

    work page arXiv

  56. [56]

    and Dong, L

    Pramanik, P. and Dong, L. (2025b). Strategic complementarities due to monetary shock under sticky price. European Journal of Statistics , 5:9--9

  57. [57]

    Pramanik, P., Graff, J., and DeCaro, M. (2024b). Analysis of a tiered pricing model for ecw clients. In International Conference on Mathematical Modeling in Physical Sciences , pages 515--535. Springer

  58. [58]

    Pramanik, P., Graff, J., and Decaro, M. (2025a). Dissecting multi-level pricing schemes in the context of ecw client engagement. arXiv preprint arXiv:2509.22669

    work page arXiv

  59. [59]

    Pramanik, P., Graff, J., and Decaro, M. (2025b). On factors influencing consumer preference in pipeline stages: an experiment. arXiv preprint arXiv:2501.03418

    work page arXiv

  60. [60]

    Pramanik, P., Graff, J., and Decaro, M. (2025c). Strategies to increase pipeline status: A case study from eclinical data. European Journal of Statistics , 5:3--3

  61. [61]

    and Maity, A

    Pramanik, P. and Maity, A. K. (2024). Bayes factor of zero inflated models under jeffereys prior. arXiv preprint arXiv:2401.03649

    work page arXiv 2024

  62. [62]

    arXiv preprint arXiv:2601.10615 , year=

    Pramanik, P., Maity, A. K., Mandal, A., and Robinson, H. K. (2026). A bayesian discrete framework for enhancing decision-making processes in clinical trial designs and evaluations. arXiv preprint arXiv:2601.10615

    work page arXiv 2026

  63. [63]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2020). Motivation to run in one-day cricket. arXiv preprint arXiv:2001.11099

    work page arXiv 2020

  64. [64]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2021). Optimal estimation of brownian penalized regression coefficients. arXiv preprint arXiv:2107.02291

    work page arXiv 2021

  65. [65]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023a). Optimization of a dynamic profit function using euclidean path integral. SN Business & Economics , 4(1):8

  66. [66]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023b). Scoring a goal optimally in a soccer game under liouville-like quantum gravity action. Operations Research Forum , 4(3):66

  67. [67]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023c). Semicooperation under curved strategy spacetime. The Journal of Mathematical Sociology , pages 1--35

  68. [68]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2024). Motivation to run in one-day cricket. Mathematics , 12(17):2739

    2024

  69. [69]

    and Perou, C

    Prat, A. and Perou, C. M. (2015). Clinical implications of the intrinsic molecular subtypes of breast cancer. The Breast , 24:S26--S35

    2015

  70. [70]

    Reid, S., Haddad, D., Tezak, A., Weidner, A., Wang, X., Mautz, B., Moore, J., Cadiz, S., Zhu, Y., and Zheng, W. (2021). Impact of molecular subtype and race on hr+, her2-breast cancer survival. Breast Cancer Research and Treatment , 189:845--852

    2021

  71. [71]

    G., Tyson, M., Egger, M., Heller, R

    Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., and Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet , 371(9612):569--578

    2008

  72. [72]

    Rose, D. P. and Vona-Davis, L. (2015). Obesity and breast cancer: Weighing the evidence. Cancer Research , 75(23):5101--5105

    2015

  73. [73]

    M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M

    Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences , 98(19):10869--10874

    2001

  74. [74]

    N., and Chen, C.-L

    Tseng, C.-H., Tu, S.-H., Chow, S. N., and Chen, C.-L. (2018). Obesity and breast cancer outcomes: a systematic review and meta-analysis. Oncotarget , 9(3):3429

    2018

  75. [75]

    and Pramanik, P

    Valdez, I. and Pramanik, P. (2025a). Association between obesity, race, and luminal subtypes of breast cancer. European Journal of Statistics , 5:12--12

  76. [76]

    and Pramanik, P

    Valdez, I. and Pramanik, P. (2025b). Exploring the interplay of adiposity, ethnicity, and hormone receptor profiles in breast cancer subtypes. arXiv preprint arXiv:2507.21348

    work page arXiv

  77. [77]

    Vikramdeo, K., Anand, S., Sudan, S., Pramanik, P., Singh, S., Godwin, A., Singh, A., and Dasgupta, S. (2024a). Abstract po3-16-05: Mitochondrial dna mutation detection in tumors and circulating extracellular vesicles of triple negative breast cancer patients for biomarker development. Cancer Research , 84(9\_Supplement):PO3--16

  78. [78]

    Vikramdeo, K., Anand, S., Sudan, S., Pramanik, P., Singh, S., Godwin, A., Singh, A., and Dasgupta, S. (2024b). Mitochondrial dna mutation detection in tumors and circulating extracellular vesicles of triple negative breast cancer patients for biomarker development. In CANCER RESEARCH , volume 84. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHI...

  79. [79]

    S., Anand, S., Sudan, S

    Vikramdeo, K. S., Anand, S., Sudan, S. K., Pramanik, P., Singh, S., Godwin, A. K., Singh, A. P., and Dasgupta, S. (2023). Profiling mitochondrial dna mutations in tumors and circulating extracellular vesicles of triple-negative breast cancer patients for potential biomarker development. FASEB BioAdvances , 5(10):412

    2023

  80. [80]

    and Pramanik, P

    Yusuf, A. and Pramanik, P. (2025a). Predictive significance of cd276/b7-h3 expression in baseline biopsies of advanced prostate carcinoma. arXiv preprint arXiv:2508.09373

    work page arXiv

Showing first 80 references.